Court filing
Exhibit 13 (Doc. 1): FDA Faers Ivermectin Adverse Events — Apter v. HHS (S.D. Tex.)
Summary
Exhibit 13 to the complaint in Case 3:22-cv-00184 in the U.S. District Court for the Southern District of Texas, filed June 2, 2022 as Document 1-13. The exhibit is a printout from the FDA Adverse Events Reporting System (FAERS) Public Dashboard for the search term Ivermectin (G) and the reaction term Death. It reports 70 total cases, 70 serious cases and 70 death cases. A table breaks the cases down by received year, with 8 cases in 2021 and 1 in 2020.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
Filed June 2, 2022 in Apter v. Department of Health and Human Services; one of 69 filings from this case.
Record facts
| Court | U.S. District Court for the Southern District of Texas (Galveston Division) |
|---|---|
| Filed | 2022-06-02 |
Cite this document
“Exhibit 13 (Doc. 1): FDA Faers Ivermectin Adverse Events — Apter v. HHS (S.D. Tex.).”
U.S. District Court for the Southern District of Texas (Galveston Division), No. 3:22-cv-00184, Doc. 1-13, filed 2022-06-02. Archived at Pandemic Darlings, https://pandemicdarlings.com/court-filings/apter-v-hhs/2022-06-02-exhibit-13-fda-faers-ivermectin/
, SHA-256 a6c124877f94f87807a7b9766436af1bd8a493d60e3bd288dddad775ba77794e.Full text
Case 3:22-cv-00184 Document 1-13 Filed on 06/02/22 in TXSD Page 1 of 2 Exhibit 13 Case 3:22-cv-00184 Document 1-13 Filed on 06/02/22 in TXSD Page 2 of 2 Search Term: Ivermectin (G) | Reaction Term: Death FDA Adverse Events Reporting System (FAERS) Public Dashboard FDA U.S. FOOD & DRUG ADMINISTRATION Home | Demographics | Reaction Group | Reaction | Listing of Cases | Disclaimer | Report a Problem | FAQ | Site Feedback | Search by Product IVERMECTIN (G) Total Cases 70 | Serious Cases (including death) 70 | Death Cases 70 Cancel Cases by Received Year Case Count by Received Year Category | Number of Cases | Percentage 2021 | 8 | 11.43% 2020 | 1 | 1.43% 2019 | 4 | 5.71% 2017 | 4 | 5.71% 2016 | 1 | 1.43% 2014 | 4 | 5.71% 2013 | 2 | 2.86% 2012 | 1 | 1.43% 2011 | 1 | 1.43% 2010 | 2 | 2.86% 2009 | 2 | 2.86% 2008 | 5 | 7.14% 2007 | 3 | 4.29% 2006 | 8 | 11.43% 2005 | 7 | 10.00% Totals | 70 | 100.00% Case Count by Received Year: 2021 8; 2020 1; 2019 4; 2017 4; 2016 1; 2014 4; 2013 2; 2012 1; 2011 1; 2010 2; 2009 2; 2008 5 | Number of Cases Data as of March 31, 2022 This page displays the number of cases identified for the product/reaction term of interest by "Received Year". "Received Year" is the year the case was received by the FDA.
File and source
- File
- gov.uscourts.txsd.1875135.1.13.pdf
- Size
- 136,131 bytes
- SHA-256
- a6c124877f94f87807a7b9766436af1bd8a493d60e3bd288dddad775ba77794e
- Original
- archive.org